The Development And Feasibility Assessment Of Canadian Quality Indicators For Atrial Fibrillation

Publication date: Available online 27 February 2016 Source:Canadian Journal of Cardiology Author(s): Jafna L. Cox, Sulan Dai, Yanyan Gong., Robert McKelvie, M. Sean McMurtry, Garth H. Oakes, Allan Skanes, Atul Verma, Stephen B. Wilton, D. George Wyse In 2010, the Canadian Cardiovascular Society (CCS) embarked on an initiative to develop pan-Canadian quality indicators (QIs) and standardized data definitions with the ultimate goal of monitoring, comparing, and contrasting national cardiovascular care and its outcomes. One of the first working groups to be established was tasked with identifying and then defining a set of QIs for atrial fibrillation/flutter (AF/AFL). The CCS “Best Practices for Developing Cardiovascular Quality Indicators” methodology was used to develop an initial catalogue of 25 QIs intended to measure critical issues around access, process, and outcomes relating to AF/AFL management. This list was subsequently pared down to 5 QIs felt to have the greatest relative importance for quality assurance and measurability so as to facilitate early adoption. Three of these QIs were finally selected to assess the feasibility of their measurement using existing administrative datasets. These were: the number of patients with a diagnosis of nonvalvular AF/AFL (NVAF/AFL) at high risk of stroke (75 years old or greater, or, CHADS2 ≥ 2) receiving an oral anticoagulant; and, the rates of stroke and major hemorrhage in patients with NVAF/AFL acc...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research